Plain-English translation of NCT06971458 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study is testing a newer, gentler way to treat ovarian cysts caused by endometriosis. Instead of surgical removal, doctors use ultrasound guidance to insert a needle into the cyst and inject ethanol sclerotherapy, a substance that helps the cyst shrink and disappear. The hope is that this approach preserves more healthy ovarian tissue compared to surgery, leading to better results when women pursue fertility treatment.
Traditional surgery to remove these cysts can damage surrounding healthy ovarian tissue and reduce the number of eggs available for fertility treatment. This study exists to see if the new minimally invasive approach produces better egg quality and pregnancy outcomes while protecting the ovary.
You likely qualify if…
You likely don't qualify if…
You will receive an ultrasound-guided needle procedure to treat your ovarian cyst with ethanol sclerotherapy, performed as an outpatient visit. After about one month of healing, you will proceed with your planned in vitro fertilization treatment. The study will track your egg quality, number of eggs retrieved, and pregnancy outcomes to see how the procedure affects your fertility results.
AI-generated summary from trial data · Sep 11, 2026 · Not medical advice
Israel
Enrollment target
~120 participants
Started
August 2022
Primary completion
December 2027
Age range
18 Years – 41 Years
Sex
Female only
Last updated on clinicaltrials.gov in May 2025.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Einat Shalom-Paz, Prof
Hillel Yaffe Medical Center
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.